orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
A new mathematical model which aims to optimise treatment for prostate cancer has been developed by experts at the University of Portsmouth. Prostate cancer is the second most common cancer among men ...
Identification of a predictive factor of metastatic castration-resistant prostate cancer patients’ response to alternative antiandrogen therapy with flutamide. This is an ASCO Meeting Abstract from ...
A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...
Even when diagnosed at an advanced stage, most prostate cancers respond well to treatment. The first line of treatment is often hormone therapy, which is very good at slowing or stopping the cancer — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results